Abeona Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	199	193	97	44	36	113
Market Cap Growth	4.97%	98.49%	121.93%	20.32%	-67.79%	-45.07%
Enterprise Value	64	124	60	36	-8	49
Last Close Price	3.66	4.47	3.98	2.38	6.25	29.30
PS Ratio	667.10	-	35.46	37.41	16.47	15.47
PB Ratio	1.56	5.50	8.37	1.98	1.17	1.51
P/TBV Ratio	1.56	5.50	8.37	1.98	1.21	2.26
EV/Sales Ratio	218.51	-	21.73	30.43	-	6.68
Debt / Equity Ratio	0.14	0.52	0.36	0.28	0.22	0.09
Asset Turnover	0.00	-	0.06	0.02	0.03	0.05
Quick Ratio	9.41	5.99	4.07	6.73	2.89	2.27
Current Ratio	9.74	6.08	4.15	6.83	3.39	2.33
Return on Equity (ROE)	75.90%	-216.57%	-260.60%	-114.85%	-117.22%	-59.96%
Return on Assets (ROA)	-29.58%	-46.41%	-46.99%	-39.34%	-31.07%	-16.19%
Return on Capital Employed (ROCE)	-39.80%	-69.50%	-95.30%	-80.20%	-91.10%	-44.40%
Earnings Yield	30.86%	-26.32%	-43.66%	-75.04%	-171.90%	-54.45%
FCF Yield	-30.87%	-24.14%	-30.09%	-82.44%	-141.30%	-23.50%
Buyback Yield / Dilution	-74.23%	-91.99%	-171.96%	-99.65%	-6.24%	-84.02%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.